Analysis of TP 53 mutation status in human cancer cell lines: a reassessment

B Leroy, L Girard, A Hollestelle, JD Minna… - Human …, 2014 - Wiley Online Library
Tumor‐derived cell lines play an important role in the investigation of tumor biology and
genetics. Across a wide array of studies, they have been tools of choice for the discovery of …

Translational models of prostate cancer bone metastasis

RB Berish, AN Ali, PG Telmer, JA Ronald… - Nature Reviews …, 2018 - nature.com
Metastatic disease is the principal cause of prostate-cancer-related mortality. Our ability to
accurately recapitulate the spread of prostate cancer to bone—the most common site of …

[HTML][HTML] In vitro and in vivo model systems used in prostate cancer research

D Cunningham, Z You - Journal of biological methods, 2015 - ncbi.nlm.nih.gov
New incidence of prostate cancer is a major public health issue in the Western world, and
has been rising in other areas of the globe in recent years. In an effort to understanding the …

p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1

B Wang, D Niu, L Lai, EC Ren - Nature communications, 2013 - nature.com
The p53 tumour suppressor has an important role in cancer cells. Here we show that p53
regulates expression of major histocompatibility complex I on the cell surface. We show that …

Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer

YZ Wang, N Wu, N Jiang - Cell Death & Disease, 2021 - nature.com
Prostate cancer is a common malignant tumor, which can spread to multiple organs in the
body. Metastatic disease is the dominant reason of death for patients with prostate cancer …

p28-Mediated Activation of p53 in G2–M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy

T Yamada, TK Das Gupta, CW Beattie - Cancer research, 2016 - AACR
Abstract p28 is an anionic cell-penetrating peptide of 28 amino acids that activates wild-type
and mutated p53, leading subsequently to selective inhibition of CDK2 and cyclin A …

Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells

Q Hong, CI Sze, SR Lin, MH Lee, RY He, L Schultz… - PloS one, 2009 - journals.plos.org
Background Tissue exudates contain low levels of serum complement proteins, and their
regulatory effects on prostate cancer progression are largely unknown. We examined …

A dominant role for p53-dependent cellular senescence in radiosensitization of human prostate cancer cells

BD Lehmann, JA McCubrey, HS Jefferson, MS Paine… - Cell cycle, 2007 - Taylor & Francis
Because p53 inactivation may limit the effectiveness of radiation therapy for localized
prostate cancer, it is important to understand how this gene regulates clonogenic survival …

Intracellular CD24 disrupts the ARF–NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation

L Wang, R Liu, P Ye, C Wong, GY Chen, P Zhou… - Nature …, 2015 - nature.com
CD24 is overexpressed in nearly 70% human cancers, whereas TP53 is the most frequently
mutated tumour-suppressor gene that functions in a context-dependent manner. Here we …

Hyperpolarized [1-13C]-Pyruvate Magnetic Resonance Spectroscopic Imaging of Prostate Cancer In Vivo Predicts Efficacy of Targeting the Warburg Effect

BT Scroggins, M Matsuo, AO White, K Saito… - Clinical Cancer …, 2018 - AACR
Purpose: To evaluate the potential of hyperpolarized [1-13C]-pyruvate magnetic resonance
spectroscopic imaging (MRSI) of prostate cancer as a predictive biomarker for targeting the …